Developing high-throughput HIV incidence assay with pyrosequencing platform. - Wikidata - wikimedia - TriplyDB

Developing high-throughput HIV incidence assay with pyrosequencing platform.

Developing high-throughput HIV incidence assay with pyrosequencing platform.

http://www.wikidata.org/entity/Q37643996

about

Identifying Recent HIV Infections: From Serological Assays to Genomics Molecular clock of HIV-1 envelope genes under early immune selection A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.Assessing Biases in the Evaluation of Classification Assays for HIV Infection Recency.Fecal bacterial microbiome diversity in chronic HIV-infected patients in China Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana Quasispecies Analyses of the HIV-1 Near-full-length Genome With Illumina MiSeq.SPMM: estimating infection duration of multivariant HIV-1 infections.Enhancement of viral escape in HIV-1 Nef by STEP vaccination.Pairwise diversity and tMRCA as potential markers for HIV infection recency Deep sequencing: becoming a critical tool in clinical virology.Moving towards a reliable HIV incidence test - current status, resources available, future directions and challenges ahead.The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards.Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimation.

P2860

Q26778001-03324854-0716-479B-A983-94D3E9C0D42F Q28601925-49AAF6AD-9D4A-4051-82D4-488862BAA383 Q33812743-CE4B8C32-F06C-44B2-8049-6B41D6F823CA Q34058732-1DB1CD52-D54B-40BA-9576-F0C66CC35C6C Q35799203-2C760447-BA79-4DFE-8998-126FE2AB65F2 Q35980520-4C05F7EC-B13F-4174-9217-1A7E6CF4834E Q36110367-8D84B0CB-EB2F-4599-A8F2-F78EDE61DA5B Q36271817-E97D1E96-8CE9-4D03-836A-6B06F3BBF069 Q37003000-93076A5B-4424-43F4-A175-5DA844520340 Q37312719-94D98589-35E3-40E6-AE92-E8D31E860453 Q37646636-5A3B3C25-2ADD-4887-97FF-856FECBEEBD9 Q38226696-62876CFA-B98A-4AFD-8644-22B2A73969AB Q38779402-C65E7ECC-0BCA-48AF-AB4A-C2E8E27B2801 Q40091554-A90B7F06-5ADB-4F2A-8359-19D28BC456B7 Q41488562-C09E19B3-297C-4AB7-BC06-CBE14EAD3C42

P2860

Developing high-throughput HIV incidence assay with pyrosequencing platform.

http://www.wikidata.org/entity/Q37643996

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Developing high-throughput HIV incidence assay with pyrosequencing platform.

@en

Developing high-throughput HIV incidence assay with pyrosequencing platform.

@nl

type

label

Developing high-throughput HIV incidence assay with pyrosequencing platform.

@en

Developing high-throughput HIV incidence assay with pyrosequencing platform.

@nl

prefLabel

Developing high-throughput HIV incidence assay with pyrosequencing platform.

@en

Developing high-throughput HIV incidence assay with pyrosequencing platform.

@nl

P1433

Q37643996-0FD3D0D6-C776-4C4A-99CB-AF9712D8AA6C

P1476

Q37643996-E2D43507-32BB-42F3-BFC6-2FB968C55227

P2093

Q37643996-37A903AA-000D-4895-B28E-14D0A92AD59D

Q37643996-50CC50B6-0DB6-425A-8B68-57E637DB0A55

Q37643996-8A333F88-0E69-488A-ADF1-271FE2EF44DC

Q37643996-8DA31286-74FA-49B8-9110-7F9335E6F0F2

Q37643996-8FE18944-AE3E-4C60-8375-39EC5415DBDE

Q37643996-9D9DD437-5D94-49DB-AA40-FD5415362380

P2860

Q37643996-094A9838-A3D0-4CC2-9EB8-35038C10AF9B

Q37643996-0BB3B7AE-2684-4795-8661-98951F7089F8

Q37643996-13D310C0-97BB-4A90-A371-855737EFC98C

Q37643996-1449F797-DA61-42A0-9261-9FB0FBFE5637

Q37643996-1BD2B011-744A-4433-B222-9EA7281B56C3

Q37643996-3151BD73-33B8-4AFB-8EE0-844701FE1AC1

Q37643996-50A9689F-A433-4DA5-A897-5FDFA66C65A2

Q37643996-5372E410-FB48-4120-B800-8053CF83C684

Q37643996-5557B2BA-45EA-4DDD-809D-59182BA40644

Q37643996-5D24FD94-675A-4825-A3C4-D83369EB3967

P304

Q37643996-721CBBDE-AA8C-42C3-9601-783FAFE961D7

P31

Q37643996-2FF5068E-DFA5-4F35-8674-3B10A7556A94

P356

Q37643996-234DB483-C262-4C6A-B10B-56298818BAB0

P407

Q37643996-997E0070-DFDF-4E74-8D92-509757F6DCD2

P433

Q37643996-A1468582-FAD1-4D64-9FAF-C381CC3C0451

P478

Q37643996-9A5BC245-2CA6-41CC-B54C-92F62CC2B525

P577

Q37643996-4C5D1C90-22E5-4303-8915-ABA19D858FB6

P698

Q37643996-E2337EC1-45F2-426E-A79E-E87C852735DA

P921

Q37643996-8B23ABD2-62E4-4597-A763-C0240667DCEB

P932

Q37643996-17A8E484-F986-49B4-834E-DB3093B3550A

P356

P1433

Journal of Virology

P1476

Developing high-throughput HIV incidence assay with pyrosequencing platform.

@en

P2093

Ha Youn Lee

http://www.w3.org/2001/XMLSchema#string

Hyo Jin Lee

http://www.w3.org/2001/XMLSchema#string

Michael P Dubé

http://www.w3.org/2001/XMLSchema#string

Nolan Goeken

http://www.w3.org/2001/XMLSchema#string

Robert Bolan

http://www.w3.org/2001/XMLSchema#string

Sung Yong Park

http://www.w3.org/2001/XMLSchema#string

P2860

A general method applicable to the search for similarities in the amino acid sequence of two proteins

A sequencing method based on real-time pyrophosphate

Viral population estimation using pyrosequencing

Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection.

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.

Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors.

Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys

Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection

P304

2977-2990

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.03128-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24371062

http://www.w3.org/2001/XMLSchema#string

P921

P932

3958066

http://www.w3.org/2001/XMLSchema#string